Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MPO | P05164 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1923453 | 0.76 | CA12 (0.38) | KDM4ECA12CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL7062212 | 0.75 | CA12 (0.37) | KDM4ECA12CA1CA2CA9 | |
| SCHEMBL15066590 | 0.73 | KDM4E (0.50) | KDM4EMEN1KMT2AGAALMNA | |
| Acetone SCHEMBL44218 | 0.73 | GAA (0.38) | KDM4ECA12CA1CA2CA9 | |
| SCHEMBL4654937 | 0.73 | CA12 (0.49) | KDM4ECA12CA1CA2CA9 | |
| SCHEMBL5669489 | 0.72 | KDM4E (0.41) | KDM4E | |
| Acetone SCHEMBL16337585 | 0.72 | GAA (0.37) | KDM4ECA12CA1CA2CA9 | |
| SCHEMBL662028 | 0.71 | SIRT3 (0.58) | KDM4ECA12CA1CA2CA9 | |
| SCHEMBL188821 | 0.71 | KDM4C (0.55) | KDM4ECA12CA1CA2CA9 | |
| SCHEMBL19611328 | 0.71 | KDM4C (0.55) | KDM4ECA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210230592-A1 | Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2021-07-29 | — | — | US | disclosed |
| US-10900037-B2 | Targeted self-assembly of functionalized carbon nanotubes on tumors | SCHEINBERG DAVID A (US) | 2021-01-26 | — | — | US | disclosed |
| US-20180327742-A1 | Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors | SCHEINBERG DAVID A (US) | 2018-11-15 | — | — | US | disclosed |
| US-9976137-B2 | Targeted self-assembly of functionalized carbon nanotubes on tumors | SCHEINBERG DAVID A (US) | 2018-05-22 | — | — | US | disclosed |
| EP-2797605-B1 | TARGETED SELF-ASSEMBLY 0F FUNCTIONALIZED CARBON NANOTUBES ON TUMORS | SLOAN KETTERING INST FOR CANCER RES (US) | 2017-07-05 | — | — | EP | disclosed |
| CN-104334178-B | Targeting self assembly of the functionalized carbon nano-tube in tumour | 斯隆-凯特琳癌症研究院 | 2017-07-04 | — | — | CN | disclosed |
| CN-104334178-A | Targeted self-assembly 0f functionalized carbon nanotubes on tumors | SLOAN KETTERING INST CANCER | 2015-02-04 | — | — | CN | disclosed |
| EP-2797605-A2 | TARGETED SELF-ASSEMBLY 0F FUNCTIONALIZED CARBON NANOTUBES ON TUMORS | Sloan Kettering Institute For Cancer Research (US) | 2014-11-05 | — | — | EP | disclosed |
| US-20140308203-A1 | Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors | SCHEINBERG DAVID A (US) | 2014-10-16 | — | — | US | disclosed |
| WO-2013101983-A2 | TARGETED SELF-ASSEMBLY 0F FUNCTIONALIZED CARBON NANOTUBES ON TUMORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2013-07-04 | — | — | WO | disclosed |